CN Patent

CN101384172B — N-[2,4-双(1,1-二甲基乙基)-5-羟基苯基]-1,4-二氢-4-氧代喹啉-3-甲酰胺的固体形式

Assigned to Vertex Pharmaceuticals Inc · Expires 2014-05-07 · 12y expired

What this patent protects

本发明涉及N-[2，4-双(1，1-二甲基乙基)-5-羟基苯基]-1，4-二氢-4-氧代喹啉-3-甲酰胺(化合物1)的固体形式、其药物组合物及其使用方法。

USPTO Abstract

本发明涉及N-[2，4-双(1，1-二甲基乙基)-5-羟基苯基]-1，4-二氢-4-氧代喹啉-3-甲酰胺(化合物1)的固体形式、其药物组合物及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101384172B
Jurisdiction
CN
Classification
—
Expires
2014-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.